Intrathecal Administration
Intrathecal Administration is a parenteral route of drug delivery characterized by the injection of therapeutic agents directly into the subarachnoid space of the spinal canal to achieve selective distribution within the cerebrospinal fluid, thereby enabling targeted pharmacological action on the central nervous system.
1.6K
Publications
86K
Citations
6.5K
Authors
1.6K
Institutions
Publications per year
2017–2026
218
Variants
Intrathecal Route
1.6K
Timothy M. Miller, Alan Pestronk, William David et al. · The Lancet Neurology · 2013 · 607 citations · Full text
Medicine, Neurology, Pharmacology +17
1–5 of 1.6K
6.5K
30
h-index
17
h-index
15
h-index
14
h-index
14
h-index
1–5 of 6.5K
1.6K
University of California San Diego
San Diego, United States
28 h-index
104 publications
9.1K citations
Stanford University
Stanford, United States
22 h-index
75 publications
4.4K citations

Wake Forest University
Winston-Salem, United States
22 h-index
72 publications
4K citations
University of California, San Francisco
San Francisco, United States
20 h-index
126 publications
5.4K citations

McGill University
Montreal, Canada
20 h-index
59 publications
3.8K citations
Marymount University
Arlington, United States
18 h-index
36 publications
1.9K citations

University of Minnesota
Minneapolis, United States
17 h-index
48 publications
3.6K citations
Osaka Medical and Pharmaceutical University
Takatsuki, Japan
17 h-index
56 publications
4.3K citations
1–8 of 1.6K
95 publications · 7.3K citations
52
h-index
81 publications · 6K citations
45
h-index
72 publications · 6.6K citations
44
h-index
116 publications · 4.5K citations
40
h-index
BJP · 42 publications · 2.7K citations
31
h-index
1–5